Company

Vitro S.A.

Vitro S.A. develops diagnostic reagents, instruments and software for oncology and infectious disease testing.

About

Vitro develops, manufactures and sells diagnostic reagents, instruments, and histopathology and molecular diagnostics software, focused on oncology and infectious diseases, for hospitals, labs and research institutions in Spain, Portugal and Turkey. Founded in 1989 and based in Sevilla, Spain, it reported FY2023 revenue of USD 30.55 mn and EBITDA of USD 3.28 mn. Its most recent deal was in March 2022, when GED Capital moved its investment into the GED Strategic Partnerships I fund. It is listed at the Seed stage.

2Funding rounds

5Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in